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Background/Aims: The objective of this study was to determine whether insulin resistance is associated with gallbladder 
stone formation in Korean women based on menopausal status.
Methods: The study included 4,125 consecutive Korean subjects (30-79 years of age). Subjects who had a medical 
history of diabetes, hypertension, dyslipidemia, other cardiovascular disorders, or hormone replacement therapy were 
excluded. The women were subdivided into two groups according to their menopausal status.
Results: Analysis of premenopausal women showed no significant differences in the homeostasis model of assessment-
insulin resistance (HOMA-IR) index between the two groups in terms of gallstone disease. The associations between the 
occurrence of gallbladder stones and age, obesity, abdominal obesity, hyperinsulinemia, and high HOMA-IR index were 
statistically significant in the analysis with postmenopausal women. In a multiple logistic regression analysis, low high 
density lipoprotein-cholesterol was an independent predictor of gallbladder stone formation in premenopausal women. 
However, the multiple logistic regression analysis also showed that age and HOMA-IR were significantly associated with 
gallbladder stone formation in postmenopausal women. In an additional analysis stratified by obesity, insulin resistance 
was a significant risk factor for gallbladder stone formation only in the abdominally obese premenopausal group. 
Conclusions: Insulin resistance may be associated with gallbladder stone formation in Korean postmenopausal women 
with abdominal obesity. 
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INTRODUCTION
Gallbladder (GB) stone disease is a common disorder 
affecting approximately 10-25% of the adult population 
in Western countries [1]. GB stone formation is multifac-
torial, and known risk factors are advancing age, female 
gender, genetics/ethnicity, obesity, rapid weight loss, diet, 
drugs, and activity [2]. The association of GB stone disease 
with metabolic abnormalities such as diabetes, dyslipid-
emia, obesity, and hyperinsulinemia has supported the 
hypothesis that GB stone formation is a type of metabolic 
syndrome [3,4].
GB stone formation is more common in women than in 
men, and estrogen is considered to be the obvious reason 
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for the gender difference. The liver has estrogen receptors, 
and the presence of endogenous estrogens causes choles-
terol saturation in the bile, inhibition of chenodeoxycholic 
acid secretion, and an increase in cholic acid level [5]. Fe-
male predominance is obvious, particularly at a young age. 
However, the gender difference narrows with increasing 
age, particularly after menopause. Moreover, female pre-
dominance is less  evident in Asia where the occurrence of 
pigmented stones is more common [2].
The epidemiological characteristics of GB stones differ 
between Asia and the west. Literature on GB stone com-
position in Korea shows that 30-40 years ago more than 
half of the GB stones were brown pigmented stones [6]. 
However, this pattern has changed rapidly, and a relative 
increase in the prevalence of cholesterol stones has been 
observed, in parallel with the changing economic status 
and diet in Korea [7-9].
Based on recent epidemiological data showing an 
increasing ratio of cholesterol stones in the Korean 
population, we hypothesized that insulin resistance plays 
a role in the development of GB stone formation depending 
on menopausal state. The objective of this study was to 
evaluate whether insulin resistance is associated with GB 
stone formation in non-diabetic Korean women based on 
menopausal status.
METHODS
Subjects
From January 2006 to December 2007, 5,592 women 
visited the Center for Health Promotion at Pusan National 
University Hospital for a comprehensive medical check-
up. Of these, 4,125 women (30-79 years of age) were 
enrolled in this study, and 1,467 subjects were excluded 
based on the following criteria that might influence 
insulin resistance and GB disease: 1,183 had a medical 
history of hypertension, dyslipidemia, diabetes, or 
hormone replacement therapy; 59 had a history of a 
cholecystectomy; 92 had ultrasonography (US) findings 
of a Clonorchis sinensis infection; 192 had US findings of 
other GB diseases, including GB poly and GB sludge; and 
eight had intrahepatic bile duct stones. The women were 
subdivided into two groups based on their responses to a 
questionnaire on their menopausal status (premenopausal 
state, n = 2,549; postmenopausal state, n = 1,576). This 
study was conducted with the approval of the Institutional 
Review Board of Pusan National University Hospital, and 
all subjects gave their informed consent to participate.
Measurements
The health information of the subjects included their 
medical history, a physical examination, responses to a 
health-related behavior questionnaire, and anthropo-
metric measurements. Data on alcohol intake and smok-
ing habits were obtained by interview. The questions on 
alcohol intake included items about the type of alcohol 
beverage, frequency of alcohol consumption on a weekly 
basis, and usual amount consumed daily. Weekly alcohol 
intake was calculated and then converted to daily alcohol 
consumption. Subjects were divided into two groups based 
on their alcohol consumption: non-drinkers, 0-180 g/wk; 
and drinkers, > 180 g/wk. Based on smoking status, they 
were classified as non-smokers or smokers (former or cur-
rent). The subjects wore light clothing without shoes for 
the height and weight measurements. Body mass index 
was calculated as the weight (kg) divided by the height 
(m) squared. Waist circumference (WC) was measured at 
a level midline between the bottom of the rib cage and the 
top of the iliac crest with a soft tape around the body with 
the subjects standing. Blood pressure was measured on 
the right arm with subjects in a sitting position after a 5 
minutes rest.
Laboratory methods
Blood samples were obtained from the antecubital vein 
and collected in evacuated plastic tubes after overnight 
fasting. The samples were subsequently analyzed at a cer-
tified laboratory at Pusan National University Hospital. 
The standard liver enzyme, total cholesterol, high-density 
lipoprotein (HDL) cholesterol, and triglyceride (TG) levels 
were measured with an enzymatic colorimetric method 
using a Hitachi 7600 Analyzer (Hitachi Co., Ltd., Tokyo, 
Japan). A Behring BN II Bephelometer (Dade Behring, 
Marburg, Germany) was used to measure high sensitivity 
C-reactive protein (hs-CRP) levels. White blood cell counts 
were assessed with an autoanalyzer (XE-2100, Sysmex, 
Tokyo, Japan). Plasma free fatty acids were measured with 
an enzyme assay kit. Fasting plasma glucose was mea-
sured by the glucose oxidase method using a Synchron LX 
20 system (Beckman Coulter, Fullerton, CA, USA). Fasting 
insulin was determined by radioimmunoassay (Diagnostic Kim SS, et al. Insulin resistance and GB stones    287
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Product Co., Los Angeles, CA, USA) using antibody-coated 
tubes. The mean intra- and inter-assay CVs were 4.2% and 
6.3%, respectively. The homeostasis model assessment of 
insulin resistance (HOMA-IR) index was calculated using 
the following formula [10]:
HOMA-IR = [fasting serum insulin (μU/mL) × fasting 
plasma glucose (mmol/L)/22.5]
US imaging
We evaluated the presence of GB stones and fatty liver 
using abdominal US (HDI 5000, Philips, Bothell, WA, 
USA) performed by skilled radiologists. After an overnight 
fast, subjects were examined in the supine position, oblique 
position right side up, during the change from one position 
to another, and in a standing position. GB stones were 
detected by the presence of strong intraluminal, gravity-
dependent echoes that produced acoustic shadowing. GB 
sludge was diagnosed as diffuse, low-amplitude echoes 
forming a fluid-fluid level. The sludge was characterized 
by homogeneous echoes or heterogeneous echoes of 2 to 5 
mm with nonshadowing echogenic foci [11]. Three grades 
were defined for fatty liver infiltration of the liver: mild, in 
which there was a slight diffuse increase in the fine echoes 
in the hepatic parenchyma with normal visualization of 
the diaphragm and intrahepatic vessel borders; moderate, 
in which there was a moderate diffuse increase in the 
fine echoes with slightly impaired visualization of the 
diaphragm and intrahepatic vessels; and severe, in which 
Table 1. Clinical and metabolic characteristics of all subjects with or without gallbladder stones
Variables
All subjects
(n = 4,125)
Without GB stone
(n = 3,952)
With GB stone
(n = 173)
p value
Age, yr  47.4 ± 9.3 47.3 ± 9.3   50.3 ± 10.4 < 0.001
Waist circumference, cm 77.9 ± 8.1 77.8 ± 8.0 79.9 ± 9.0 < 0.001
BMI, kg/m
2   23.4 ± 2.8 23.3 ± 2.8   24.0 ± 2.9 < 0.001
SBP, mmHg  117.5 ± 17.2 117.4 ± 17.2  119.3 ± 16.0 0.113
dBP, mmHg     72.2 ± 10.5   72.1 ± 10.5   73.4 ± 10.0 0.178
Total cholesterol, mg/dL  196.5 ± 34.8 196.3 ± 34.7   200.7 ± 35.6 0.256
Triglyceride, mg/dL
a   98.2 ± 55.5   98.0 ± 55.7 103.0 ± 51.7 0.154
HDL-C, mg/dL   60.5 ± 13.8   60.5 ± 13.8   58.8 ± 13.9 0.017
LDL-C, mg/dL 120.4 ± 31.0 120.2 ± 31.0   124.8 ± 31.3 0.075
AST, IU/L 21.2 ± 7.2 21.0 ± 7.1 21.4 ± 7.3 0.402
ALT, IU/L   18.7 ± 10.2   18.7 ± 10.1   20.3 ± 12.2 0.284
FFA, μmol/L    457.8 ± 190.3   457.6 ± 190.0     463.7 ± 198.6 0.245
hs-CRP, mg/dL
a    0.11 ± 0.35    0.11 ± 0.35    0.12 ± 0.23 0.045
Fasting glucose, mg/dL    87.1 ± 13.3   86.9 ± 12.9   89.5 ± 21.3 0.121
Fasting insulin, IU/mL
a     4.42 ± 2.78   4.40 ± 2.76   4.86 ± 3.08 0.028
HOMA-IR
a     0.97 ± 0.70   0.97 ± 0.69   1.09 ± 0.76 0.019
Smoking status
b 260 (6.3) 253 (6.4)  7 (4.0) 0.212
Alcohol intake
c 228 (5.5) 222 (5.6)  6 (3.5) 0.226
Fatty liver
d  732 (17.7)  700 (17.7)  32 (18.5) 0.791
MS 229 (5.6) 213 (5.4) 16 (9.2) 0.030
Values are presented as mean ± Sd or number (%).
GB, gallbladder; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C, high density lipoprotein-
cholesterol; LDL-C, low density lipoprotein-cholesterol; AST, aspartate aminotransferase; ALT, alanine aminotransferase; FFA, free fatty 
acid; CRP, C-reactive protein; HOMA-IR, insulin resistance assessed by homeostasis model assessment; MS, metabolic syndrome.
a Log-transformed values were used for comparison.
b Current or past smoker.
c > 180 g/wk.
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there was a marked increase in the fine echoes with poor 
or no visualization of the diaphragm, intrahepatic vessels, 
and posterior portion of the right lobe of the liver [12]. Any 
degree of fatty infiltration including mild, moderate, and 
severe infiltrations, was considered a fatty liver.
Definition of metabolic syndrome
We used the International Diabetes Federation (IDF) 
criteria for diagnosing metabolic syndrome [13]. These 
criteria recommend a lower WC cutoff for the Asian 
population than the Caucasian population because Asians 
are predisposed to metabolic abnormalities at a lower WC. 
Therefore, we defined central obesity as a WC of 85 cm 
in females, based on the recommendation of the Korean 
Society for the Study of Obesity [14].
Statistical analysis
Statistical analyses were performed using SPSS version 
12.0 (SPSS Inc., Chicago, IL, USA). Descriptive statistics 
are reported as mean ± SD. Categorical variables are re-
ported as frequencies and proportions. An independent 
two-sample t test was used to compare two independent 
groups. Pearson’s χ
2 test was employed to analyze cat-
egorical data, as appropriate. Distributions of continu-
ous variables were examined for skewness and kurtosis, 
and logarithm-transformed values of nonnormally 
Table 2. Clinical and metabolic characteristics of women 
Variables
Premenopausal state (n = 2,549) Postmenopausal state (n = 1,576)
Without GB 
stone
(n = 2,467)
With GB stone
(n = 82)
p value
Without GB 
stone
(n = 1,485)
With GB stone
(n = 91)
p value
Age, yr
Waist circumference, cm
BMI, kg/m
2
SBP, mmHg
dBP, mmHg
Total cholesterol, mg/dL
Triglyceride, mg/dL
a
HDL-C, mg/dL
LDL-C, mg/dL
AST, IU/L
ALT, IU/L
FFA, μmol/L
hs-CRP, mg/dL
a
Fasting glucose, mg/dL
Fasting insulin, IU/mL
a
HOMA-IR
a
Smoker
b
Alcohol drinking
c
Fatty liver
d
MS
  41.5 ± 5.1
75.9 ± 7.5
22.9 ± 2.8
 113.5 ± 15.0
  70.0 ± 9.6
 187.0 ± 30.7
  89.0 ± 50.8
  61.2 ± 13.7
 111.8 ± 26.9
  19.8 ± 6.7
 17.2 ± 9.6
   440.1 ± 183.9
   0.10 ± 0.28
  85.5 ± 12.1
   4.14 ± 2.69
  0.90 ± 0.68
183 (6.9)
175 (7.1)
  340 (13.8)
  64 (2.6)
 41.3 ± 5.1
 76.6 ± 7.8
 23.2 ± 2.8
   114.0 ± 13.5
 70.6 ± 9.4
 184.0 ± 29.9
   90.1 ± 50.0
   57.8 ± 13.8
   111.5 ± 27.8
 19.3 ± 7.2
    18.4 ± 13.1
   449.8 ± 198.4
   0.10 ± 0.15
   88.7 ± 26.3
    4.11 ± 2.97
   0.92 ± 0.74
2 (2.4)
4 (4.9)
11 (13.4)
2 (2.4)
0.751
0.606
0.276
0.770
0.570
0.382
0.847
0.029
0.941
0.474
0.409
0.639
0.879
0.271
0.914
0.795
0.114
0.447
0.916
0.931
 56.9 ± 6.0
 81.0 ± 8.0
 24.1 ± 2.7
 123.9 ± 18.5
   75.7 ± 10.7
   211.6 ± 35.6
 113.0 ± 60.0
    59.5 ± 13.9
  134.3 ± 32.1
23.5 ± 7.3
   21.2 ± 10.5
   486.6 ± 196.2
   0.14 ± 0.45
    89.3 ± 13.6
   4.83 ± 2.82
   1.09 ± 0.70
83 (5.6)
48 (3.2)
359 (24.2)
149 (10.0)
58.3 ± 6.5
82.9 ± 8.9
24.7 ± 2.8
124.0 ± 16.6
75.9 ± 9.9
215.7 ± 33.7
114.6 ± 50.6
59.8 ± 14.0
136.8 ± 29.6
23.4 ± 6.8
   22.0 ± 11.1
  476.2 ± 199.1
   0.13 ± 0.28
  90.1 ± 15.7
  5.54 ± 3.02
  1.25 ± 0.74
5 (5.5)
2 (2.2)
21 (23.1)
14 (15.4)
0.030
0.029
0.049
0.948
0.875
0.279
0.457
0.860
0.462
0.892
0.494
0.624
0.874
0.608
0.031
0.029
0.970
0.585
0.812
0.104
Values are presented as mean ± Sd or number (%).
GB, gallbladder; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C, high density lipoprotein-
cholesterol; LDL-C, low density lipoprotein-cholesterol; AST, aspartate aminotransferase; ALT, alanine aminotransferase; FFA, free fatty 
acid; CRP, C-reactive protein; HOMA-IR, insulin resistance assessed by homeostasis model assessment; MS, metabolic syndrome.
aLog-transformed values were used for comparison.
bCurrent or past smoker.
c > 180 g/wk.
dAny degree of fatty infiltration on ultrasonography.Kim SS, et al. Insulin resistance and GB stones    289
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distributed variables were used for comparison between 
the two groups. The odds ratios (ORs) of HOMA-IR 
were calculated with reference to the lowest quartile for 
continuous variables or the lowest category for categorical 
variables. Analyses were conducted after the subjects 
were stratified by obesity to identify the association 
Table 3. Age-adjusted odds ratios for gallbladder stone formation based on menopausal state
Variables
Premenopausal state
(n = 2,549)
Postmenopausal state
(n = 1,576)
GB stones,
n (%)
Age-adjusted
ORs
95% CI
(p value)
GB stones,
n (%)
Age-adjusted
ORs
95% CI
(p value)
Waist circumference ≥ 85 cm
BMI ≥ 25 kg/m
2
Glucose ≥ 100 mg/dL
SBP ≥ 130 or DBP ≥ 85 mmHg
Total cholesterol ≥ 240 mg/dL
Triglyceride ≥ 150 mg/dL
HDL-C < 50 mg/dL
HOMA-IR quartile 
   Q1
   Q2
   Q3
   Q4
 MS 
11 (3.5)
22 (4.4)
  7 (5.6)
10 (2.8)
  5 (3.6)
  9 (4.2)
26 (5.0)
18 (2.8)
25 (3.9) 
18 (2.8)
21 (3.3)
  2 (3.0)
1.11
1.53
0.85
0.87
1.17
1.37
1.87
1
1.41
1.00
1.17
0.94
0.58-2.11 (0.71)
0.93  -2.52 (0.10)
0.85-4.22 (0.12)
 0.44-1.71 (0.68)
0.46-2.96 (0.74)
 0.67-2.77 (0.37)
 1.16-3.01 (0.01)
Ref.
0.76-2.60 (0.28)
0.52-1.95 (0.99)
0.62-2.22 (0.63)
0.23-3.93 (0.94)
34 (7.2)
39 (6.9)
  9 (4.6)
39 (6.8)
23 (7.0)
 19 (6.2)
22 (5.6)
16 (4.1)
24 (6.1)
  8 (4.2)
43 (7.2)
14 (8.6)
1.43
1.37
0.73
1.25
1.27
1.04
0.90
1
1.53
1.03
1.84
1.63
0.92-2.22 (0.11)
0.89-2.11 (0.15)
0.36-1.48 (0.39)
0.81-1.93 (0.32)
0.78-2.08 (0.88)
0.61-1.76 (0.34)
0.54-1.47 (0.67)
Ref.
0.80-2.93 (0.20)
0.43-2.44 (0.95)
  1.02-3.31 (0.03)
  0.90-2.95 (0.11)
GB, gallbladder; CI, confidence interval; OR, odds ratio; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood 
pressure; HDL-C, high density lipoprotein-cholesterol; HOMA-IR, insulin resistance assessed by homeostasis model assessment; Q, 
quartile; Ref., reference population group; MS, metabolic syndrome. 
Table 4. Multivariate logistic regression analysis with gallbladder stone formation as the dependent variable based 
on menopausal state
Variables Multivariate-adjusted OR
a 95% CI p value
Premenopausal state
Age, yr 0.98 0.94-1.03 0.44
BMI ≥ 25 kg/m
2 1.63 0.90-2.96 0.11
WC ≥ 85 cm 0.84 0.40-1.75 0.63
HDL-C < 50 mg/dL 1.81 1.08-3.05 0.02
Glucose ≥ 100 mg/dL 2.18 0.91-5.20 0.08
HOMA-IR 0.81 0.56-1.19 0.29
Postmenopausal state
Age, yr 1.03 1.00-1.07 0.05
BMI ≥ 25 kg/m
2 1.08 0.64-1.82 0.77
WC ≥ 85 cm 1.17 0.69-1.99 0.56
HOMA-IR 1.37 1.02-1.84 0.04
OR, odds ratio; CI, confidence interval; BMI, body mass index; WC, waist circumference; HDL-C, high density lipoprotein-cholesterol; 
HOMA-IR, insulin resistance assessed by homeostasis model assessment.
a Multivariate models using the backward likelihood method were adjusted for age, smoking status, alcohol intake, body mass index, 
waist circumference, glucose, lipid profiles, blood pressure, and HOMA-IR as independent variables.290    The Korean Journal of Internal Medicine Vol. 26, No. 3, September 2011
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between insulin resistance and GB stones based on 
obesity. Multivariate logistic analysis, using a backward 
procedure on the basis of likelihood ratios, was conducted 
to determine the independent risk factors for GB stones 
based on menopausal status. All p values are two-
tailed, and p values < 0.05 were considered statistically 
significant.
RESULTS
Of the 4,125 women examined, 173 (4.2%) had GB 
stones. In comparison with women without GB stones, 
those with GB stones were significantly older and had a 
higher WC, BMI, hs-CRP, fasting insulin, and HOMA-IR. 
Moreover, women with GB stones had a significantly lower 
HDL-cholesterol level than those without GB stones (Table 
1). Metabolic syndrome, as defined by IDF criteria, was 
more frequently observed in women with GB stones (9.2% 
vs. 5.4, p = 0.030).
As shown in Table 2, subjects were subdivided into 
two groups according to their menopausal status. Only 
the HDL-cholesterol level differed significantly between 
premenopausal women with and without GB stones. 
However, significant differences were observed for 
age, WC, BMI, fasting insulin, and HOMA-IR among 
postmenopausal women with and without GB stones. 
In age-adjusted logistic regression analyses, only low 
HDL-cholesterol was significantly associated with the risk 
of GB stone formation in premenopausal women (Table 3). 
Analysis of postmenopausal women revealed an increased 
risk of GB stone formation for those in the fourth quartile 
of HOMA-IR in comparison with those in the lowest 
quartiles (age-adjusted OR, 1.84; 95% confidence interval 
[CI], 1.02 to 3.31; p = 0.03).
The multivariate logistic regression analysis for GB 
stone formation was adjusted for age, smoking habits, 
drinking habits, BMI, WC, glucose, lipid profiles, blood 
pressure and HOMA-IR as independent variables. In 
the multivariate model, only low HDL-cholesterol was 
significantly associated with GB stone formation in 
premenopausal women. However, age and HOMA-IR 
among postmenopausal women remained significantly 
associated with GB stone formation in this adjusted 
analysis (Table 4).
An additional analysis stratified by WC showed that 
HOMA-IR was significantly associated with an increased 
prevalence of GB stones only in the higher WC group in 
postmenopausal women (OR, 1.54; 95% CI, 1.01 to 2.36; 
p =0.04). However, no significant association between 
HOMA-IR and the prevalence of GB stones was observed 
after the subjects were stratified by BMI (Table 5).
DISCUSSION
This is the first study to investigate the relationship 
between insulin resistance and GB stone formation in 
Korean women based on menopausal status. We found 
that different factors may serve to promote GB stone 
formation according to menopausal status in Korean 
women. Insulin resistance was associated with GB stone 
formation in Korean women after menopause, and this 
association was only observed in postmenopausal women 
Table 5. Insulin resistance and gallbladder stone formation stratified by obesity in postmenopausal women
HOMA-IR GB stones, n (%) Multivariate -adjusted OR
a 95% CI p value
Waist circumference, cm 
< 85 (n = 1,105)
≥ 85 (n = 471)
57 (5.2)
34 (7.2)
1.16
1.54
0.74-1.83
1.01-2.36
0.52
0.04
BMI, kg/m
2
< 25 (n = 1,012)
≥ 25 (n = 564)
52 (5.1)
39 (6.9)
1.20
1.47
0.75-1.93
0.98-2.21
0.45
0.06
GB, gallbladder; OR, odds ratio; CI, confidence interval; HOMA-IR, insulin resistance assessed by homeostasis model assessment; 
BMI, body mass index.
a Multivariate-adjusted ORs were adjusted for age, smoking status, alcohol intake, body mass index, waist circumference, glucose, lipid 
profiles, and blood pressure.Kim SS, et al. Insulin resistance and GB stones    291
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who were centrally obese.
Hyperinsulinemia and insulin resistance are common 
factors linking cholesterol GB stones, diabetes, and obesity 
[15,16]. Insulin may increase GB stone formation through 
a mechanism in which insulin increases the activity of hy-
droxyl-3-methyglutaryl-coenzyme A reductase and stimu-
lates bile acid-independent flow of bile into perfused rat 
liver [17,18]. Scragg et al. [19] first demonstrated that mean 
plasma insulin concentration is higher in both male and 
female patients with GB stone disease, regardless of their 
age and TG levels. In a large-scale study, the risk of GB 
disease increased with levels of fasting insulin in Western 
women but not in Western men [16]. Among nondiabetic 
women, the prevalence of clinical GB disease increased 
with increasing insulinemia in a large, population-based 
study [20]. However, this relationship was not significant 
after adjusting for potential confounders. All of these earli-
er studies examined Western populations. A recent report 
showed that insulin resistance was positively associated 
with the occurrence of GB stones in nondiabetic Korean 
men, regardless of obesity [21]. In the present study, we 
found that the risk of GB stone formation was higher in the 
highest quartile than in the lowest quartile of HOMA-IR 
in postmenopausal women. Moreover, insulin resistance 
was an independent risk factor in Korean postmenopausal 
women in a multivariate analysis.
Obesity is a well-established risk factor for GB stone for-
mation because this condition increases hepatic secretion 
of cholesterol [2]. The risk is particularly high in women 
and increases linearly with increasing obesity [22]. Thus, 
gallstone disease is closely related to abdominal obesity 
[23]. In Western women, the abdominal circumference 
and waist-to-hip ratio are associated with an increased 
risk of cholecystectomy, independent of BMI [23]. WC is a 
better indicator of abdominal fat than BMI and has proven 
to be rather predictive for metabolic complications. In this 
study, insulin resistance was significantly associated with 
GB stone formation in the abdominally obese group (WC 
> 85 cm) of postmenopausal women. This relationship 
between insulin resistance and GB stone formation was 
absent in the BMI-defined obese group, emphasizing the 
importance of abdominal obesity in GB stone formation.
Estrogen is the main factor responsible for the differ-
ence between males and females in terms of GB stone 
formation. One study showed that exogenous estrogens, 
administered either transdermally or orally, affect physi-
ological markers in a pattern that favors GB stone forma-
tion [24]. The use of low-dose oral contraceptives has a 
relatively weak effect that may decrease with time [25]. 
An increased risk of GB stone formation was observed in 
clinical trials of postmenopausal women who underwent 
estrogen therapy [26,27]. In the present study, insulin 
resistance was not regarded as a main risk factor for GB 
stone formation in premenopausal women, because endog-
enous estrogen mainly affects GB stone formation. How-
ever, insulin resistance was one of the main factors for GB 
stone formation in postmenopausal women in whom the 
endogenous estrogen effect would be absent.
Although GB stones predominantly consist of choles-
terol in Western subjects, no conclusive evidence links 
dyslipidemia and GB stones [28]. The low density lipopro-
tein cholesterol level has a weak correlation with GB stone 
formation, and low HDL cholesterol and high TG levels 
are positively associated with GB stones [29]. Analysis of 
premenopausal women in our study revealed that HDL-
cholesterol level was significantly lower in subjects with 
GB stones; however, we did not find any component of dys-
lipidemia related to metabolic syndrome that could be cor-
related with GB stone formation in either premenopausal 
or postmenopausal women.
This study had certain limitations. First, no informa-
tion was available on family history and history of parity. 
Parity is a significant risk factor for GB stone formation, 
and pregnancy is a high-risk period for GB stone forma-
tion [30,31]. Second, we were unable to identify the exact 
types of GB stones present. Pigmented stones may still be 
a significant component of GB stones in relatively older 
subjects, although a relative increase in the prevalence 
of cholesterol stones was recently reported in Korea. 
Moreover, we excluded subjects with several confound-
ers such as those with C. sinensis infections, intrahepatic 
duct stones, and a previous history of a cholecystectomy. 
It may be necessary to distinguish the exact types of GB 
stones and to determine the role of insulin resistance in 
GB stone formation, because the relationship between 
insulin resistance and pigmented stone formation remains 
unknown.
In conclusion, insulin resistance may be associated with 
GB stone formation in Korean postmenopausal women, 
in parallel with the changing economic status and diet in 
Korea. Thus, insulin resistance may represent a causal link 
between central obesity and GB stone formation in Korean 292    The Korean Journal of Internal Medicine Vol. 26, No. 3, September 2011
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postmenopausal women.
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